MOLNATRIS/Molnupiravir 200mg Capsules is an experiment antiviral drug. It is a prodrug of the synthetic nucleoside derivative N4 – hydroxycytidine and exerts its antiviral action of copying errors during viral RNA replication.
It is well tolerated and has a potent antiviral efficacy.
- It was developed for the treatment of influenza.
- MOLNATRIS/Molnupiravir 200mg Capsule reduces the replication of SARS-CoV-2 and prevents infectious virus with rapid speed.
- Ongoing trials of the medicine state that the medicine prevents the progression of COVID-19 and eliminates onward transmission of SARS-CoV-2.
- Talk to your doctor about all the pros and cons of MOLNATRIS/Molnupiravir medicine.
- Inform your doctor about all your medical history and tablet that you already intake to avoid contradictions.
- Maintain hygiene and do not come in contact with infected persons.
- Do not skip/discontinue the dose for effective treatment.
- Maintain proper time period between two doses. Do not overlap the doses.
- Monitor your health periodically.